Emendo Biotherapeutics: EmendoBio Acquired by AnGes
EmendoBio Inc., a leader in next-generation novel nuclease discovery and gene editing technologies, today announced that AnGes, Inc.,
Read full article »
Emendo is a biotechnology company that develops and commercializes gene-editing therapeutics for the treatment of genetic diseases.
Read more